News
AstraZeneca’s rare disease business, Alexion, has partnered with British health tech Pangaea Data to fund the startup’s development of an AI tool for detecting hypophosphatasia (HPP). Through ...
AstraZeneca’s rare disease business, Alexion, has partnered with British health tech Pangaea Data to fund the startup’s development of an AI tool for detecting hypophosphatasia (HPP). Through ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback